Hyperemia Gene Set

Dataset DisGeNET Gene-Disease Associations
Category disease or phenotype associations
Type disease
Description The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).|The presence of an increased amount of blood in a part or organ; engorgement. (Experimental Factor Ontology, EFO_0003822)
External Link https://www.disgenet.org/browser/0/1/0/C0020452
Similar Terms
Downloads & Tools

Genes

61 genes associated with the disease Hyperemia in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

Symbol Name
ADA adenosine deaminase
ADCYAP1 adenylate cyclase activating polypeptide 1 (pituitary)
ADIPOQ adiponectin, C1Q and collagen domain containing
ADRB1 adrenoceptor beta 1
ADRB2 adrenoceptor beta 2, surface
AFP alpha-fetoprotein
AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
AMPD1 adenosine monophosphate deaminase 1
ANGPT2 angiopoietin 2
APOE apolipoprotein E
BDKRB2 bradykinin receptor B2
CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
CAT catalase
CD59 CD59 molecule, complement regulatory protein
CEBPZ CCAAT/enhancer binding protein (C/EBP), zeta
COX1
COX2
CYP2J2 cytochrome P450, family 2, subfamily J, polypeptide 2
DHCR24 24-dehydrocholesterol reductase
DLD dihydrolipoamide dehydrogenase
ESR1 estrogen receptor 1
EXTL3 exostosin-like glycosyltransferase 3
FLNA filamin A, alpha
HGF hepatocyte growth factor (hepapoietin A; scatter factor)
HMOX2 heme oxygenase 2
HNF1A HNF1 homeobox A
HRH1 histamine receptor H1
HRH2 histamine receptor H2
HRH3 histamine receptor H3
IFNB1 interferon, beta 1, fibroblast
IL10 interleukin 10
IL1B interleukin 1, beta
IL2 interleukin 2
IL9 interleukin 9
ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
KNG1 kininogen 1
LAD1 ladinin 1
LIPC lipase, hepatic
MDFIC MyoD family inhibitor domain containing
MMP9 matrix metallopeptidase 9
MPO myeloperoxidase
MTOR mechanistic target of rapamycin (serine/threonine kinase)
NOS2 nitric oxide synthase 2, inducible
NOS3 nitric oxide synthase 3 (endothelial cell)
NT5E 5'-nucleotidase, ecto (CD73)
OSM oncostatin M
P2RY12 purinergic receptor P2Y, G-protein coupled, 12
PTGS1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
PTH parathyroid hormone
PTPN11 protein tyrosine phosphatase, non-receptor type 11
PTX3 pentraxin 3, long
SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
TAC1 tachykinin, precursor 1
TBCC tubulin folding cofactor C
TEK TEK tyrosine kinase, endothelial
TNF tumor necrosis factor
TREX1 three prime repair exonuclease 1
VEGFA vascular endothelial growth factor A
VPS51 vacuolar protein sorting 51 homolog (S. cerevisiae)
ZNF143 zinc finger protein 143